Clinical trials are more complex than ever before, driving the industry to develop and adopt new ways to manage clinical supplies and address new challenges.
Fast Chain™ demand led supply effectively addresses the limitations of older models, but how exactly does it work and what benefits can be realized that other models just can’t deliver? Read Now.
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier era, depriving sponsors of clinical supply models with the flexibility, speed and efficiency their programs demand. Now, that may be about to change with the advent of demand led supply (DLS), a clinical supply model tailored to today’s trials.